Crossref
The Efficacy and Toxicity of Bevacizumab in Combination With Gemcitabine in Patients With Recurrent Ovarian Cancer
Clinical Ovarian Cancer · 2011
DOI: 10.1016/j.cloc.2011.04.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von Kerri S. Bevis und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bevis, K. S., Erwin, J. L., Barnes, M. N., & Straughn, J. M. (2011). The Efficacy and Toxicity of Bevacizumab in Combination With Gemcitabine in Patients With Recurrent Ovarian Cancer. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2011.04.004
Vancouver
Bevis KS, Erwin JL, Barnes MN, Straughn JM. The Efficacy and Toxicity of Bevacizumab in Combination With Gemcitabine in Patients With Recurrent Ovarian Cancer. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2011.04.004
BibTeX
@article{Bevis2011,
author = {Bevis, Kerri S. and Erwin, Jamie L. and Barnes, Mack N. and Straughn, J. Michael},
title = {The Efficacy and Toxicity of Bevacizumab in Combination With Gemcitabine in Patients With Recurrent Ovarian Cancer},
journal = {Clinical Ovarian Cancer},
year = {2011},
doi = {10.1016/j.cloc.2011.04.004}
}
EUVIMED